(CPRX) Catalyst - Performance 59.7% in 12m
Compare CPRX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
90.14%
#3 in Group
Rel. Strength
92.02%
#642 in Universe
Total Return 12m
59.74%
#26 in Group
Total Return 5y
378.57%
#6 in Group
P/E 16.8
57th Percentile in Group
P/E Forward 12.3
48th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 11.1%
100th Percentile in Group
12m Total Return: CPRX (59.7%) vs XBI (-2.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8% | 23.5% | 161% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
2.55% | 23.2% | 41.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-8.48% | 7.43% | 35.1% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
0.56% | 12.5% | 38.1% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-1.7% | 17.1% | 0.22% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-8.13% | -22.5% | 4.98% | 30.8 | 20.4 | 0.27 | 61.5% | 31.6% |
KMDA NASDAQ Kamada |
-5.51% | 32.3% | -8.24% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
6.82% | -5.27% | 21% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: CPRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CPRX
Total Return (including Dividends) | CPRX | XBI | S&P 500 |
---|---|---|---|
1 Month | -8.83% | -7.84% | -4.31% |
3 Months | 3.30% | -13.34% | -7.85% |
12 Months | 59.74% | -2.25% | 10.76% |
5 Years | 378.57% | -18.04% | 106.31% |
Trend Score (consistency of price movement) | CPRX | XBI | S&P 500 |
1 Month | -44.2% | -17.6% | -35.6% |
3 Months | 8.30% | -91.9% | -89.7% |
12 Months | 89.2% | -36.5% | 58.3% |
5 Years | 92.9% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #112 | -1.07% | -4.72% |
3 Month | #31 | 19.2% | 12.1% |
12 Month | #26 | 63.4% | 44.2% |
5 Years | #5 | 484% | 132% |
FAQs
Does CPRX Catalyst outperforms the market?
Yes,
over the last 12 months CPRX made 59.74%, while its related Sector, the SPDR S&P Biotech (XBI) made -2.25%.
Over the last 3 months CPRX made 3.30%, while XBI made -13.34%.
Over the last 3 months CPRX made 3.30%, while XBI made -13.34%.
Performance Comparison CPRX vs Indeces and Sectors
CPRX vs. Indices CPRX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.66% | -4.52% | 13.6% | 49.0% |
US NASDAQ 100 | QQQ | -2.62% | -4.59% | 13.6% | 47.7% |
US Dow Jones Industrial 30 | DIA | 1.41% | -3.05% | 13.3% | 52.8% |
German DAX 40 | DAX | 2.0% | -5.02% | -4.86% | 36.2% |
Shanghai Shenzhen CSI 300 | CSI 300 | 5.87% | -5.33% | 15.0% | 51.1% |
Hongkong Hang Seng | HSI | 1.61% | -5.95% | 11.7% | 45.7% |
India NIFTY 50 | INDA | 6.77% | -10.4% | 12.0% | 57.9% |
Brasil Bovespa | EWZ | -0.41% | -10.8% | 9.07% | 65.2% |
CPRX vs. Sectors CPRX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.52% | -3.25% | 4.83% | 37.3% |
Consumer Discretionary | XLY | -3.01% | -4.79% | 10.4% | 45.4% |
Consumer Staples | XLP | 6.80% | -11.6% | 8.25% | 50.3% |
Energy | XLE | 2.69% | 2.80% | 16.0% | 71.7% |
Financial | XLF | 1.30% | -4.05% | 5.47% | 40.4% |
Health Care | XLV | 2.36% | -3.86% | 15.6% | 59.5% |
Industrial | XLI | 1.17% | -4.76% | 13.2% | 52.8% |
Materials | XLB | 2.59% | -4.32% | 20.5% | 65.1% |
Real Estate | XLRE | 4.17% | -6.92% | 15.7% | 44.6% |
Technology | XLK | -4.47% | -4.31% | 18.4% | 53.5% |
Utilities | XLU | 3.49% | -10.5% | 10.5% | 39.3% |
Aerospace & Defense | XAR | -0.22% | -8.53% | 2.30% | 32.8% |
Biotech | XBI | 0.21% | -0.99% | 26.7% | 62.0% |
Homebuilder | XHB | 1.09% | -2.81% | 28.6% | 67.7% |
Retail | XRT | 2.13% | -5.90% | 17.7% | 63.4% |